![Scott H. Gillis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Scott H.
Gillis served as President & Chief Executive Officer at NUCRYST Pharmaceuticals Corp.
from 1999 to 2007.
He also served as President & Director at Pericor Science, Inc. Additionally, he holds an MBA from Xavier University and an undergraduate degree from Salem State University.
Eerdere bekende functies van Scott H. Gillis
Bedrijven | Functie | Einde |
---|---|---|
NUCRYST Pharmaceuticals Corp.
![]() NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | President | 22-08-2007 |
Pericor Science, Inc.
![]() Pericor Science, Inc. Pharmaceuticals: MajorHealth Technology Pericor Science, Inc. develops novel therapeutic products. It manufactures renal cell therapy devices. The company was founded by Howard Green and Philippe Djian in 1999 and is headquartered in Waltham, MA. | President | - |
Opleiding van Scott H. Gillis
Xavier University | Masters Business Admin |
Salem State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
NUCRYST Pharmaceuticals Corp.
![]() NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Health Technology |
Pericor Science, Inc.
![]() Pericor Science, Inc. Pharmaceuticals: MajorHealth Technology Pericor Science, Inc. develops novel therapeutic products. It manufactures renal cell therapy devices. The company was founded by Howard Green and Philippe Djian in 1999 and is headquartered in Waltham, MA. | Health Technology |